Your session is about to expire
← Back to Search
Sample Collection Methods for Respiratory Infection Testing
Study Summary
This trial is testing new ways to collect samples from people with respiratory infections like COVID-19, which is the 3rd leading cause of death worldwide. These new collection methods are less invasive and reduce risk to healthcare workers.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 19 or older and had a nasopharyngeal swab test at UNMC.
- Group 1: Oral Capsule saliva
- Group 2: Blood by standard finger stick method
- Group 3: Saliva passive drool
- Group 4: NP saline wash by study device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants will the clinical trial accommodate?
"Affirmative. Clinicaltrials.gov contains evidence that this clinical trial is actively looking for participants; it was first listed on July 1st 2023 and the most recent update occurred on July 5th, 2023. The study hopes to include 1000 patients from one medical site."
Has enrollment for this experiment commenced?
"Per information available on clinicaltrials.gov, this medical trial is currently in search of participants and was initially posted on July 1st 2023. The study has been amended most recently as of the 5th day of July 2023."
Share this study with friends
Copy Link
Messenger